A detailed history of Exane Derivatives transactions in Malibu Boats, Inc. stock. As of the latest transaction made, Exane Derivatives holds 7 shares of MBUU stock, worth $307. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 1,823 99.62%
Holding current value
$307
Previous $105,000 100.0%
% of portfolio
0.0%
Previous 0.03%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$48.72 - $61.16 $88,475 - $111,066
-1,816 Reduced 99.62%
7 $0
Q1 2022

Apr 22, 2022

SELL
$56.77 - $70.44 $21,004 - $26,062
-370 Reduced 16.87%
1,823 $105,000
Q4 2021

Jan 28, 2022

SELL
$63.01 - $77.03 $41,523 - $50,762
-659 Reduced 23.11%
2,193 $150,000
Q3 2021

Oct 26, 2021

SELL
$66.31 - $84.87 $31,165 - $39,888
-470 Reduced 14.15%
2,852 $199,000
Q2 2021

Jul 28, 2021

SELL
$70.34 - $87.59 $78,499 - $97,750
-1,116 Reduced 25.15%
3,322 $243,000
Q1 2021

Apr 30, 2021

SELL
$61.81 - $91.94 $112,865 - $167,882
-1,826 Reduced 29.15%
4,438 $353,000
Q4 2020

Jan 27, 2021

BUY
$50.5 - $67.88 $316,332 - $425,200
6,264 New
6,264 $391,000

Others Institutions Holding MBUU

About MALIBU BOATS, INC.


  • Ticker MBUU
  • Exchange NASDAQ
  • Sector Consumer Cyclical
  • Industry Recreational Vehicles
  • Shares Outstandng 20,383,500
  • Market Cap $895M
  • Description
  • Malibu Boats, Inc. engages in the design, engineering, manufacturing, marketing, and sale of a range of recreational powerboats. It operates through three segments: Malibu, Saltwater Fishing, and Cobalt. The company offers performance sport boats, and sterndrive and outboard boats under the Malibu, Axis, Pursuit, Maverick, Cobia, Pathfinder, Hew...
More about MBUU
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.